Characteristics | Model 1 | Model 2 | Model 3 | Model 4 |
---|---|---|---|---|
COR (95% CI) | aOR (95% CI) | aOR (95% CI) | aOR (95% CI) | |
Age (years) | ||||
< 35 | 1.08 (0.58–2.01) | |||
≥ 35 | 1 (ref.) | |||
Sex | ||||
Male | 0.60 (0.33–1.11) | |||
Female | 1 (ref.) | |||
Facility type | ||||
Primary | 1.42 (0.73–2.74) | |||
Secondary | 1 (ref.) | |||
Years of practice | ||||
< 5 | 0.10 (0.54–1.84) | |||
≥ 5 | 1 (ref.) | |||
Professional qualification | ||||
Certificate | 4.38 (1.31–14.61)† | 4.38 (1.31–14.61) | 3.59 (0.10–12.10) | |
Diploma | 2.28 (1.10–4.73) | 2.28 (1.10–4.73)* | 1.89 (0.83–4.14) | |
Degree/HND | 1 (ref.) | 1 (ref.) | 1 (ref.) | |
Cadre | ||||
CHW | 1 (ref.) | |||
Doctors/Nurses | 0.90 (0.44–1.83) | |||
Med. Lab/Pharm tech | 0.57 (0.26–1.25) | |||
Had training on malaria case management | ||||
Yes | 3.07 (1.54–6.08)† | 2.58 (1.26–5.29)* | 2.63 (1.26–5.44)* | |
No | 1 (ref.) | 1 (ref.) | 1 (ref.) | |
mRDT stock level in the facility influenced prescription | ||||
Yes | 0.86 (0.39–1.91) | |||
No | 1 (ref.) | |||
Presence of fever in the patient influenced prescription | ||||
Yes | 4.59 (2.29–9.21)† | 2.83 (1.33–5.98)* | 2.53 (1.18–5.43)* | |
No | 1 (ref.) | 1 (ref.) | 1 (ref.) | |
Patients expectations to be given antimalarial influenced prescription | ||||
Yes | 4.36 (2.12–8.95)† | 3.18 (1.48–6.80)* | 3.06 (1.42–6.58)* | |
No | 1 (ref.) | 1 (ref.) | 1 (ref.) | |
Clinical judgement of the HCW influenced prescription | ||||
Yes | 1.46 (0.64–3.33) | |||
No | 1 (ref.) | |||
Availability of alternative diagnostic tool (microscopy) | ||||
Yes | 1.60 (0.76–3.37) | |||
No | 1 (ref.) |